Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company , upon attaining the age of 75 (seventy-five) years.

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Dated: 24th September, 2026 To, To, The Secretary (DCS/Compliance), The Secretary (Listing/Compliance), Corporate Relationship Department, Corporate Relationship Department, BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, Mumbai-400001 Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Mumbai – 400051 Subject: Continuous Disclosure of material events or information in pursuance of Regulation 30 read with sub-para 7 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 as amended from time to time. Reference: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Script Code: 524396; NSE Symbol: BIOFILCHEM; ISIN: INE829A01014) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”) read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026 regarding continuous disclosure requirements for listed entities; we are enclosing following events which where transacted and approved with requisite majority by members in 41st Annual General Meeting of the Company held on 23rd September, 2026 for which disclosure as required under sub-clause 7 of Para A of Part A of Schedule III required: 1. Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non- Executive Independent Director of the Company, upon attaining the age of 75 (seventy-five) years. Details required under Regulation 30 of the SEBI Listing Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as “Annexure-I”. Further, aforesaid disclosure shall also be available on the website of the Company at www.biofilgroup.net and shall also be submitted in XBRL mode within prescribed time limit. The 41st Annual General Meeting of the Company held on 23rd September, 2026 commenced at 03:03 P.M. and concluded at 03:17 P.M. However Combined Scrutinizer Report received from Scrutinizer as on today i.e. 24th September, 2026. You are requested to please take on record the above said information for your reference and further needful. Thanking You, Yours faithfully, FOR BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739 ANNEXURE-I Details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- PoD2/I/3762/2026 dated January 30, 2026 Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company, upon attaining the age of 75 (seventy-five) years. Sr. No. Particulars Disclosure 01 Reason for change viz. Confirmation of members be and are hereby appointment, re-appointment, obtained in the 41st Annual General Meeting held on resignation, removal, death or 23rd September, 2026 for continuation of otherwise directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company notwithstanding attaining the age of 75 (seventy-five) years, pursuant to Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 02 Date of appointment/re- Confirmation of members be and are hereby appointment/cessation and obtained in the 41st Annual General Meeting held on term of appointment/re- 23rd September, 2026 for continuation of appointment Directorship of Mr. Ashok Kumar Ramawat on attaining the age of 75 years on 27th September, 2027. 03 Brief Profile Mr. Ashok Kumar Ramawat has completed Bachelors Degree in Science. He possesses 46 years of post-qualification experience and a good exposure in Pharmaceuticals Industry. 04 Disclosure of relationships Mr. Ashok Kumar Ramawat is not related to any of between Directors the Directors or Key Managerial Personnel of the Company. The 41st Annual General Meeting of the Company commenced at 03:03 P.M. and concluded at 03:17 P.M. However, a combined scrutinizer report was received on today i.e. September, 24, 2026 from the scrutinizer. FOR BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739